These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain? Iwaki-Egawa S; Watanabe Y; Fujimoto Y Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235 [TBL] [Abstract][Full Text] [Related]
3. Development and resolution of colitis in mice with target deletion of dipeptidyl peptidase IV. Detel D; Pugel EP; Pucar LB; Buljevic S; Varljen J Exp Physiol; 2012 Apr; 97(4):486-96. PubMed ID: 22125312 [TBL] [Abstract][Full Text] [Related]
4. Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice. Baticic L; Detel D; Kucic N; Buljevic S; Pugel EP; Varljen J J Cell Biochem; 2011 Nov; 112(11):3322-33. PubMed ID: 21751235 [TBL] [Abstract][Full Text] [Related]
5. CD26/DPP IV in experimental and clinical organ transplantation. Korom S; de Meester I; Belyaev A; Schmidbauer G; Schwemmle K Adv Exp Med Biol; 2003; 524():133-43. PubMed ID: 12675233 [TBL] [Abstract][Full Text] [Related]
6. Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses. Vora KA; Porter G; Peng R; Cui Y; Pryor K; Eiermann G; Zaller DM BMC Immunol; 2009 Apr; 10():19. PubMed ID: 19358731 [TBL] [Abstract][Full Text] [Related]
7. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation. Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353 [TBL] [Abstract][Full Text] [Related]
8. CD26 (dipeptidyl peptidase i.v.) on human T lymphocytes does not mediate adhesion of these cells to endothelial cells or fibroblasts. Mattern T; Reich C; Schönbeck U; Ansorge S; Demuth HU; Loppnow H; Ulmer AJ; Flad HD Immunobiology; 1998 Feb; 198(4):465-75. PubMed ID: 9562870 [TBL] [Abstract][Full Text] [Related]
9. Reduced expression of dipeptidyl peptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients. Uematsu T; Urade M; Yamaoka M; Yoshioka W J Oral Pathol Med; 1996 Oct; 25(9):507-12. PubMed ID: 8959560 [TBL] [Abstract][Full Text] [Related]
10. CD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma model. Kruschinski C; Skripuletz T; Bedoui S; Tschernig T; Pabst R; Nassenstein C; Braun A; von Hörsten S Clin Exp Immunol; 2005 Jan; 139(1):17-24. PubMed ID: 15606609 [TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase IV/CD26 in T cell activation, cytokine secretion and immunoglobulin production. Fan H; Yan S; Stehling S; Marguet D; Schuppaw D; Reutter W Adv Exp Med Biol; 2003; 524():165-74. PubMed ID: 12675236 [No Abstract] [Full Text] [Related]
12. Serum dipeptidyl peptidase IV activity correlates with the T-cell CD26 antigen. Elgün S; Keskinege A; Akan H; Karaca L Clin Chem Lab Med; 1999 Aug; 37(8):839-40. PubMed ID: 10536934 [No Abstract] [Full Text] [Related]
14. Dipeptidylpeptidase IV (DPIV) and alanyl-aminopeptidases (AAPs) as a new target complex for treatment of autoimmune and inflammatory diseases-proof of concept in a mouse model of colitis. Bank U; Tadje J; Helmuth M; Stefin S; Täger M; Wolke C; Wischeropp A; Ittenson A; Reinhold D; Ansorge S; Lendeckel U Adv Exp Med Biol; 2006; 575():143-53. PubMed ID: 16700517 [No Abstract] [Full Text] [Related]
15. Structure of CD26 (dipeptidyl peptidase IV) and function in human T cell activation. Hegen M; Kameoka J; Dong RP; Morimoto C; Schlossman SF Adv Exp Med Biol; 1997; 421():109-16. PubMed ID: 9330687 [No Abstract] [Full Text] [Related]
16. [Dipeptidyl peptidase IV in inflammatory bowel diseases (DPP IV/CD26)]. Pučar LB; Detel D; Varljen J Arh Hig Rada Toksikol; 2012 Mar; 63(1):75-100. PubMed ID: 22450208 [TBL] [Abstract][Full Text] [Related]
17. Identification of the target of monoclonal antibody A6H as dipeptidyl peptidase IV/CD26 by LC MS\MS. Hass GM; Meyer JL; Newitt RA; Labuda T; Brown L; Aebersold R; Vessella RL Hybridoma; 2001 Aug; 20(4):231-6. PubMed ID: 11604108 [TBL] [Abstract][Full Text] [Related]
18. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Busso N; Wagtmann N; Herling C; Chobaz-Péclat V; Bischof-Delaloye A; So A; Grouzmann E Am J Pathol; 2005 Feb; 166(2):433-42. PubMed ID: 15681827 [TBL] [Abstract][Full Text] [Related]
19. CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes. van Lingen RG; van de Kerkhof PC; Seyger MM; de Jong EM; van Rens DW; Poll MK; Zeeuwen PL; van Erp PE Br J Dermatol; 2008 Jun; 158(6):1264-72. PubMed ID: 18384439 [TBL] [Abstract][Full Text] [Related]
20. Histochemical and immunocytochemical localization of dipeptidyl peptidases II and IV in human gingiva. Kennett CN; Cox SW; Eley BM J Periodontol; 1996 Sep; 67(9):846-52. PubMed ID: 8884640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]